https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » India
Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Mahad API plant acquisition : Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has completed the acquisition of an API manufacturing facility in Mahad in Maharashtra, India. The company’s subsidiary Olon India will initiate all the activities the next April 1st as per the strategy of Olon after an intensive transition period that […]

Lupin out-licenses MALT1 inhibitor program to AbbVie in $977m deal

Indian pharma company Lupin has out-licensed its MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program to US biopharma company AbbVie in a deal potentially worth around $977 million. Lupin and AbbVie have forged a partnership in this regard which gives the US biopharma company the exclusive global rights to develop and commercialize the […]

Continue reading …
MedGenome says cancer vaccine approach can help in Lynch Syndrome treatment

MedGenome, an Indian genomics research and diagnostics startup, in a recent study has found out that using a cancer vaccine approach can be applied in Lynch Syndrome treatment. The study conducted by MedGenome examined the feasibility of a personalized cancer vaccine approach by detecting potential immunogenic tumor specific alterations. Lynch Syndrome or hereditary non-polyposis colorectal […]

Continue reading …
Sandoz US to sell dermatology and oral solids businesses to Aurobindo

Pharma acquisition news : Sandoz US, a subsidiary of Swiss pharma company Novartis, has agreed to sell its dermatology and oral solids businesses to Indian pharma company Aurobindo Pharma in a deal that could fetch it up to $1 billion. As per the terms of the deal, the Indian pharma company through its subsidiary Aurobindo […]

Continue reading …
Italian CDMO Olon acquires API manufacturing plant in India

Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has acquired a generics chemical operations API manufacturing plant in Mahad in the Indian state of Maharashtra. According to Olan CEO Paolo Tubertini, the acquisition of AP manufacturing facility in India will give the company scope to speed up growth by adding new CDMO projects […]

Continue reading …